Fig 5.

Psoriasis and atopic dermatitis. Respondent selection of patient groups with psoriasis and atopic dermatitis with unmet therapeutic needs for whom clinicians would be interested in using a personalized molecular test to guide systemic therapy selection. A, Respondents (N = 265) were asked to select all applicable moderate-to-severe patient groups with atopic dermatitis or psoriasis for which the clinicians would prefer to use a molecular test to guide their systemic therapy selection. Difficult to treat disease regions included nail/scalp/genital involvement or body surface area >10%. B, The patient group selections from (A) were summed per respondent and presented as parts of a whole.